Paper2906641
Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material.
von Koenig CH and 2 others. J Clin Microbiol, 1988. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material. Papers, record 2906641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2906641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bordetella pertussis | Major topic |
| Adult | |
| Bordetella | |
| Child | |
| Culture Media | |
| Humans | |
| Nasal Mucosa | |
| Whooping Cough |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4324651 | A simple chemically defined medium for the production of phase I Bordetella pertussis. | J Gen Microbiol | 1970 | https://conductscience.org/library/papers/4324651 | PubMed |
| 2 | 4329893 | Symposium on pertussis immunization, in honor of Dr. Pearl L. Kendrick in her eightieth year: current diagnostic procedures in whooping cough. | Health Lab Sci | 1971 | https://conductscience.org/library/papers/4329893 | PubMed |
| 3 | 4342612 | Selective medium for the isolation of bordetella pertussis and parapertussis. | J Clin Pathol | 1972 | https://conductscience.org/library/papers/4342612 | PubMed |
| 4 | 198430 | Enrichment medium for the isolation of Bordetella. | J Clin Microbiol | 1977 | https://conductscience.org/library/papers/198430 | PubMed |
| 5 | 6298274 | Cephalexin-supplemented Jones-Kendrick charcoal agar for selective isolation of Bordetella pertussis: comparison with previously described media. | J Clin Microbiol | 1983 | https://conductscience.org/library/papers/6298274 | PubMed |
| 7 | 6309661 | Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis. | Infect Immun | 1983 | https://conductscience.org/library/papers/6309661 | PubMed |
| 8 | 6096397 | Importance of culture in laboratory diagnosis of Bordetella pertussis infections. | J Clin Microbiol | 1984 | https://conductscience.org/library/papers/6096397 | PubMed |
| 9 | 2872229 | Comparison of blood-free medium (cyclodextrin solid medium) with Bordet-Gengou medium for clinical isolation of Bordetella pertussis. | J Clin Microbiol | 1986 | https://conductscience.org/library/papers/2872229 | PubMed |
| 11 | 6306047 | Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I. | J Clin Microbiol | 1983 | https://conductscience.org/library/papers/6306047 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42012981 | Protocol for visualization and quantitative analysis of murine lung immunological architecture using iBALT-UNMAP following bacterial challenge. | STAR Protoc | 2026 | https://conductscience.org/library/papers/42012981 | PubMed |
| 34603306 | Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture. | Front Immunol | 2021 | https://conductscience.org/library/papers/34603306 | PubMed |
| 25198773 | Caspase-1-independent interleukin-1β is required for clearance of Bordetella pertussis infections and whole-cell vaccine-mediated immunity. | PLoS One | 2014 | https://conductscience.org/library/papers/25198773 | PubMed |
| 23092514 | Lack of cross-protection against Bordetella holmesii after pertussis vaccination. | Emerg Infect Dis | 2012 | https://conductscience.org/library/papers/23092514 | PubMed |
| 19750010 | O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. | PLoS One | 2009 | https://conductscience.org/library/papers/19750010 | PubMed |
| 19737902 | The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis. | Infect Immun | 2009 | https://conductscience.org/library/papers/19737902 | PubMed |
| 19707559 | Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. | PLoS One | 2009 | https://conductscience.org/library/papers/19707559 | PubMed |
| 9316885 | Laboratory diagnosis of pertussis: state of the art in 1997. | J Clin Microbiol | 1997 | https://conductscience.org/library/papers/9316885 | PubMed |
| 7957264 | Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection. | Eur J Clin Microbiol Infect Dis | 1994 | https://conductscience.org/library/papers/7957264 | PubMed |
| 7927683 | Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis. | Infect Immun | 1994 | https://conductscience.org/library/papers/7927683 | PubMed |
| 2550232 | Detection of Bordetella pertussis by determination of adenylate cyclase activity. | Eur J Clin Microbiol Infect Dis | 1989 | https://conductscience.org/library/papers/2550232 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2906641
GET https://conductscience.org/api/papers/v1/2906641/authors